Global cooperation is needed to ensure the rapid progress in robotics benefits societies.
Humanoid bionic robots made by Chinese robotics company EX Robot demonstrate their functionality at the 2023 World Robot Conference in Beijing, China, August 18, 2023. Credit: Costfoto/NurPhoto via AP Photos
Last month, the 2023 World Robot Conference unfolded in Beijing, a spectacle that sparked global interest in recent technological advances in robotics. Over 100 enterprises bringing over 600 exhibits attended the conference, showcasing robot applications in the manufacturing, health, education, services, and medical sectors. A panorama of robotic marvels included humanoid bionic robots and quadrupeds, as well as robots for agricultural harvesting, industrial welding and surgery. Among the s
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
When Congress resumes next month, the BioSecure Act will be one of its top priorities. The bill, which could dramatically reorder the global pharmaceutical supply chain, is the latest example of the U.S. trying to exorcize China from its supply chains, and it will have a profound effect on WuXi Apptec, the most important drugmaker American patients have never heard of.
The economics journalist talks about his travels to see how the substances we need for modern life are extracted and produced, the trade-offs involved and the fragility of so many of the supply chains and...
September 17th: Strategies for Identifying Military End Users
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy